Virala CNS-infektioner - Infektion.net

24. Langenberg AG, Corey L, Ashley RL, Leong WP, Straus SE.A prospective study of new infections with herpes simplexvirus type 1 and type 2. Chiron HSV Vaccine Study Group.N Engl J Med 1999; 341:1432-8.24x Johnston C, Margaret A, Selke S, Remington M, Corey L,Wald A. Herpes simplex viremia during primary genitalinfection. J Infect Dis 2008; 198:31-4.25. Svensson A, Bergin AM, Löwhagen GB, Tunbäck P, BellnerL, Padyukov L, et al. A 3’-untranslated region polymorphismin the TBX21 gene encoding T-bet is a risk factor for genitalherpes simplex virus type 2 infection in humans. J Gen Virol2008; 89:2262-8.26. Franzen-Röhl E. In: Diagnosis in aseptic menigitis and immuneresponse in herpes simplex virus infections. ThesisKarolinska Institutet, 2009.27. Benedetti JK, Corey L, Ashley R. Recurrence rates in genitalherpes after symptomatic first-episode infection. Ann InternMed 1994; 1221:847-54.28. Aurelius E. Neurological disease in herpes simplex virustype 2 (HSV-2) infection. In: Studahl, Cinque, Bergström,editors. Herpes simplex viruses. N.Y.: Taylor and Francis;2006 p. 317-32.29. Chin RH, Ross BC, Taylor KI, Yung AP, Johnson PD. Chronicmeningitis due to herpes simplex virus in an immunocompetenthost. Eur J Clin Microbiol Infect Dis 1996; 15:650-3.30. Brenton DW. Hypoglycorrhachia in herpes simplex type 2meningitis. Arch Neurol 1980; 37:317.31. Schmutzhard J, Merete Riedel H, Zweygberg Wirgart B,Grillner L. Detection of herpes simplex virus type 1, herpessimplex virus type 2, and varicella-zostervirus in skin lesions.Comparison of real-time PCR, nested PCR and virusisolation. J Clin Virol 2004; 29:120-6.32. Danve-Szatanek C, Aymard M, Thouvenot D, Morfin F, AgiusG, Bertin I, et al. Surveillance network for herpes simplexvirus resistance to antiviral drugs: 3-year follow-up. J ClinMicrobiol 2004; 42:242-9.33. Levy DM, Sagar HJ. Herpes simplex type 2 meningitistreated with acyclovir. Levy DM, Sagar HJ. Postgrad Med J1984; 60:282-3.34. Schlesinger Y, Tebas P, Gaudreault-Keener M, Buller RS,Storch GA. Herpes simplex virus type 2 meningitis in theabsence of genital lesions: improved recognition with use ofthe polymerase chain reaction. Clin Infect Dis 1995; 20:842-8.35. Cohen BA, Rowley AH, Long CM Herpes simplex type 2in a patient with Mollaret’s meningitis: demonstration bypolymerase chain reaction. Ann Neurol 1994; 35:112-6.36. Berger JR. Benign aseptic (Mollaret‘s) meningitis after genitalherpes. Lancet 1991; 337:1360-1.37. Farmakoterapi vid herpes simplex-, varicella och herpesinfektioner– behandlingsrekommen da tioner. Informationfrån Läkemedelsverket 2005; 4:35-47.38. Lycke J, Malmeström C, Ståhle L. Acyclovir levels in serumand cerebrospinal fluid after oral admini stration of valacyclovir.Antimicrob Agents Chemother 2003; 47:2438-41.39. Hevron JE Jr. Herpes simplex virus type 2 meningitis. ObstetGynecol 1977; 49:622-4.40. Corey L, Spear PG. Infections with herpes simplex viruses(1). N Engl J Med 1986; 314:686-91.27